—

Lantheus Holdings Inc(LNTH)— 同業公司組

數據截至2026-11-20 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Lantheus Holdings Inc的Closelook綜合評分為59/100,在同業公司組內排名第2位(共7家)——組內評分最高的是Laboratorios Farmaceuticos ROVI(62/100)。

名稱綜合動能品質估值訊號距52週高點
LNTH Lantheus Holdings Inc59747352ok8.7%
ROVI.MC Laboratorios Farmaceuticos ROVI62577442info26%
IRWD Ironwood Pharmaceuticals Inc58767782info18.7%
KNSA Kiniksa Pharmaceuticals Ltd58966117ok5.5%
GALDY GALDERMA GROUP AG56705921ok9.8%
BHC.TO Bausch Health Companies Inc55945084ok6.7%
FAGR.BR Fagron NV55755555ok2.6%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-11-20

Quick answers

Lantheus Holdings Inc在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Ironwood Pharmaceuticals Inc (IRWD)、Kiniksa Pharmaceuticals Ltd (KNSA)、GALDERMA GROUP AG (GALDY)、Bausch Health Companies Inc (BHC.TO)、Fagron NV (FAGR.BR)。

LNTH相對同業公司的評分如何?

Lantheus Holdings Inc的綜合評分為59/100,組內排名第2位(共7家),截至2026-11-20;組內最高綜合評分為Laboratorios Farmaceuticos ROVI(62/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.